New and Emerging Medical Entities

All Items

• 

  Phylogenetic pattern of SARS-CoV-2 from COVID-19 patients from Bosnia and Herzegovina: lessons learned to optimize future molecular and epidemiological approaches

  Teufik Goletic, Rijad Konjhodzic, Nihad Fejzic, Sejla Goletic, Toni Eterovic, Adis Softic, Aida Kustura, Lana Salihefendic, Maja Ostojic, Maja Travar, Visnja Mrdjen, Nijaz Tihic, Sead Jazic, Sanjin Musa, Damir Marjanovic, Mirsada Hukic
• 

  SARS-CoV-2 virus outbreak and the emergency public health measures in Bosnia and Herzegovina: January – July, 2020

  Mirsada Hukic, Mirza Ponjavic, Emin Tahirovic, Almir Karabegovic, Elvir Ferhatbegovic, Maja Travar, Fadila Serdarevic

  111-116
• 

  Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches

  Dikhnah Alshehri, Omar Saadah, Mahmoud Mosli, Sherif Edris, Rashad Alhindi, Ahmed Bahieldin
• 

  The first two months of the COVID-19 pandemic in Bosnia and Herzegovina: Single-center experience

  Jurica Arapović , Siniša Skočibušić

  396-400
• 

  SARS-CoV-2 infection of the nervous system: A review of the literature on neurological involvement in novel coronavirus disease-(COVID-19)

  Alvin Oliver Payus, Constance Liew Sat Lin, Malehah Mohd Noh, Mohammad Saffree Jeffree, Raymond Azman Ali

  283-292
• 

  Comparative study of three rat models of stress urinary incontinence

  Fu Qiang, Liao Guo-long

  87-90
• 

  Using the BITOLA system to identify candidate genes for Parkinson's disease

  Amela Karić, Alen Karić

  185-189
• 

  Single-cell analysis: Advances and future perspectives

  Emir Hodzic

  313-314